Home > Drug Search >
  • company_query: Aileron Therapeutics
  •   > 
Drug Filter
Category:
chemistry (28) biology (1)
Status:
Approved (1) Phase Ⅲ (2) Phase Ⅱ (18) Phase Ⅰ (7) IND Filing (1)
Clinical Stage:
Pending (6) Active (13) Discontinued (8)
Indication:
Acute lymphoblastic leukaemia (ALL) (1) Acute myeloid Leukemia (AML) (3) Alzheimer's disease (AD) (2) Amyotrophic lateral sclerosis (ALS) (1) Anxiety (1) Arrhythmia (1) Arthritis (1) Attention deficit hyperactivity disorder (ADHD) (1) Breast cancer (1) Candidiasis (1) Chronic myeloid leukemia (CML ) (1) Cognitive disorders (1) Depression (2) Dyslipidemia (1) Pancreatitis (1) HIV infection (1) Hypertriglyceridemia (1) Inflammatory bowel disease (1) Somatotropin deficiency (1) Major depressive disorder (MDD) (1) Malignancies (1) Melanoma (1) Multiple sclerosis (MS) (1) Myelodysplastic syndrome (MDS) (1) Neuropathic pain (1) Osteoarthritis (OA) (1) Parkinson's disease (PD) (2) Postmenopausal osteoporosis (1) Psoriasis (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Type 2 diabetes (1) Ankylosing Spondylitis (AS) (1) Pain (2) Stroke (2) Diabetes (1) Glioblastoma (1) Plaque psoriasis (1) Hypogonadism (1) Vasomotor symptoms (1) Lipodystrophy (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top